Low-dose aspirin linked to 70% lower dementia risk, but there's a catch
AI KEY TAKEAWAYS (TL;DR)
- A common, inexpensive medication could hold an unexpected clue to preventing dementia
- Researchers found that older adults with a specific genetic profile had a 70% lower relative risk of dementia when taking low-dose aspirin, even though previous studies found no overall protective effect
- The discovery suggests that genetics could help explain why some people benefit while others do not
Why it matters: Bridges breakthrough research with real-world solutions to advance human knowledge and ecological wellbeing.
A common, inexpensive medication could hold an unexpected clue to preventing dementia. Researchers found that older adults with a specific genetic profile had a 70% lower relative risk of dementia when taking low-dose aspirin, even though previous studies found no overall protective effect. The discovery suggests that genetics could help explain why some people benefit while others do not.
A common, inexpensive medication could hold an unexpected clue to preventing dementia. Researchers found that older adults with a specific genetic profile had a 70% lower relative risk of dementia when taking low-dose aspirin, even though previous studies found no overall protective effect. The discovery suggests that genetics could help explain why some people benefit while others do not.
This development, featured by www.sciencedaily.com, represents an inspiring step forward in science. By spotlighting constructive solutions and practical breakthroughs, it demonstrates the tangible impact of dedicated teamwork and innovation.
Explore Breakthrough Tech Innovations & Trending Global Deals
Discover handpicked digital advancements, high-speed tools, and special offers curated for NewsDeals readers.
Deepen your curiosity with BooksDeals
Discover AI-curated reads, astrophysics classics, and breakthrough science biographies tailored to your intellectual goals.
Visit BooksDeals.pro